Shire Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.

Rhythm Pharmaceuticals is a global biopharmaceutical company based in Boston, MA, dedicated to transforming the lives of patients with rare neuroendocrine diseases through advanced care and precision medicine. The company focuses on addressing the root causes of conditions such as hyperphagia, insatiable hunger, and obesity, ensuring that patients receive the most appropriate treatment options. Committed to a stigma-free care environment, Rhythm Pharmaceuticals envisions a world where patients and their families can lead fulfilling lives. With a robust pipeline of treatment options and a collaborative workplace culture, the company is poised for continued growth and innovation in the field of rare diseases. Generated from the website

Hammer and Company is dedicated to preserving and spreading the legacy of Dr. Michael Hammer, a pioneer in process redesign and management whose innovative ideas have significantly influenced organizations worldwide. With a focus on education and consulting, the company continues to uphold Hammer's groundbreaking methodologies and create impactful training programs for process practitioners. Under the guidance of FCB Partners, Hammer and Company delivers the acclaimed Process Mastery courses, focusing on practical skills in process management and transformation. These programs, developed from Dr. Hammer's research, equip business leaders to effectively adopt and optimize process-centered organizational strategies. Generated from the website